RxC International’s Richard J. Tinsley to Present at PBIRG Annual General Meeting
MORRISTOWN, New Jersey – May 14, 2015 – RxC International today announced that Richard J. Tinsley, MBA, MEd, a senior partner in the firm, will present at this year’s PBIRG Annual General Meeting, which will take place May 17-20, 2015, in New Orleans. Tinsley will participate in a panel to discuss the future of healthcare. This year’s PBIRG Annual General Meeting will cover a wide range of topics on the future of healthcare.
“The healthcare environment is changing rapidly, and stakeholders are shifting focus towards increasing quality of care while reducing costs,” said Subbarao Jayanthi, Managing Partner at RxC International. “Rich has been advising life sciences clients on how best to navigate through the evolving healthcare environment, and he’s considered an expert in this area,” added Jayanthi.
Tinsley plans to address several important developments in the U.S. healthcare system, including:
- the need for holistic and targeted approaches to manage the care continuum
- the need for stakeholder (provider, payer, and patient) collaboration for long-term value creation
- the role of evolving ACOs in enhancing the quality of healthcare
- balancing health outcomes and economics
- the need for integrated delivery networks to effectively manage information
Tinsley was recently appointed to the Massachusetts Board of Pharmacy, and he has previously held leadership roles at Bain & Company and Putnam Associates. Tinsley holds an undergraduate degree in finance from Wharton at University of Pennsylvania as well as an MBA and Masters in Education from Stanford University. He joined RxC International as a senior partner in March of 2015.
About RxC International
RxC International is a global life sciences management consulting firm specializing in corporate strategy, new product development, and commercialization. RxC International brings strategic and operational expertise to its clients via a unique consulting delivery model. RxC International clients include leading pharmaceutical and biotechnology companies as well as other specialty life sciences companies such as vaccines, biosimilars, generics, and medical device companies. Based in Morristown, New Jersey, RxC International services clients worldwide. Additional information about RxC International can be found at www.rxcinternational.com.
Source: RxC International. For more information, contact Frank Koos, Head of Business Development at RxC International at 855-792-7920 or at Info@RxCInternational.com.